Gilder Gagnon Howe & Co’s Eli Lilly LLY Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,069	Closed	-$4.63M	–	268
2025 Q3	$4.63M	Sell	6,069 -1,181	-16%	-$879K	0.05%	155
2025 Q2	$5.65M	Sell	7,250 -12,198	-63%	-$9.48M	0.06%	137
2025 Q1	$16.1M	Sell	19,448 -153,470	-89%	-$128M	0.21%	91
2024 Q4	$133M	Sell	172,918 -44,044	-20%	-$36.5M	1.44%	17
2024 Q3	$192M	Sell	216,962 -34,785	-14%	-$31.3M	2.3%	9
2024 Q2	$228M	Sell	251,747 -10,439	-4%	-$8.35M	2.86%	6
2024 Q1	$204M	Sell	262,186 -32,385	-11%	-$23M	2.55%	7
2023 Q4	$172M	Sell	294,571 -9,656	-3%	-$5.64M	2.36%	9
2023 Q3	$163M	Sell	304,227 -13,290	-4%	-$6.85M	2.49%	8
2023 Q2	$149M	Buy	317,517 +21,450	+7%	+$9M	2.04%	11
2023 Q1	$102M	Buy	296,067 +69,310	+31%	+$23.4M	1.68%	18
2022 Q4	$83M	Buy	226,757 +51,615	+29%	+$18.3M	1.55%	14
2022 Q3	$56.6M	Buy	175,142 +172,139	+5,732%	+$54.5M	0.99%	25
2022 Q2	$974K	Buy	+3,003	New	+$901K	0.02%	199
2016 Q1	–	Sell	-5,167	Closed	-$435K	–	250
2015 Q4	$435K	Sell	5,167 -17	-0.3%	-$1.41K	0.01%	194
2015 Q3	$434K	Buy	+5,184	New	+$438K	0.01%	211

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Gilder Gagnon Howe & Co's LLY Position: Q4 2025 in Review

Gilder Gagnon Howe & Co sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 6,069 shares — an estimated $4.63M sold.

Gilder Gagnon Howe & Co first reported a position in LLY in Q3 2015 and held it in 16 quarters. The position peaked at $228M in Q2 2024. 4,429 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

Gilder Gagnon Howe & Co reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 6,069 Eli Lilly shares in Q4 2025, an estimated $4.63M.
Gilder Gagnon Howe & Co first reported a position in Eli Lilly in Q3 2015 and held it in 16 quarters.
Gilder Gagnon Howe & Co's Eli Lilly position peaked at $228M in Q2 2024.
4,429 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2025, filed 17 Feb 2026.